ChemAxon

TetraScience Announces YTD 2022 Highlights Including 111% ARR Growth, 400% Network Growth, and Product and Category Expansion; Counts 13 of the World's 25 Largest BioPharmas as Customers

Retrieved on: 
Tuesday, August 2, 2022
Cloud, Tetra, Name, ARR, TPN, R, EPAM, ChemAxon, CTC, Investment, Industry, Research, Benitec Biopharma, CEO, Quality control, NDR, Solution, Risk, Deloitte, QC, Technology, Science, Research and development, Growth, Informatics, List of life sciences, Renewable energy, Fine chemical, Software, BIOVIA

TetraScience has added 5 new top 25 global pharma customers thus far in 2022, giving it 13 of the top 25 worldwide as it grew net new ARR by 111%.

Key Points: 
  • TetraScience has added 5 new top 25 global pharma customers thus far in 2022, giving it 13 of the top 25 worldwide as it grew net new ARR by 111%.
  • After a year-long product-market fit analysis in 2021, TetraScience's newly announced biotech business has grown 183% year-over-year.
  • TetraScience is the Scientific Data Cloud company with a mission to accelerate scientific discovery and improve and extend human life.
  • Through the Tetra Partner Network, market-leading vendors access the power of our cloud to help customers maximize the value of their data.

Chemaxon Joins the Tetra Partner Network to Help Customers Accelerate Drug Delivery

Retrieved on: 
Wednesday, June 29, 2022
Cloud, Tetra, Drawing, View, CEO, Research, University, RMIT Design Hub, R, Industry, Partnership, Education, Software, Solution, AI, DMTA, Assay, Design, Data science, Multimedia, Fine chemical, ChemAxon

"Chemaxon is an industry leader with flexible solutions that support computational chemistry,"said Simon Meffan-Main, Ph.D., Vice President, Tetra Partner Network.

Key Points: 
  • "Chemaxon is an industry leader with flexible solutions that support computational chemistry,"said Simon Meffan-Main, Ph.D., Vice President, Tetra Partner Network.
  • Trusted by over one million active users, Chemaxon is renownedfor industry-leadingsoftware supporting scientific discovery with calculation, search and drawing tools.
  • "By partnering with TetraScience, Chemaxon can automatically ingest Tetra Data so that customers can analyze more scientific data at faster speeds and with greater ease," said Richard Jones, CEO, Chemaxon.
  • We are thrilled to partner with TetraScience and use Tetra Data to help customers accelerate chemical compound discovery, development and manufacturing."

New year, New Beginning: Chemaxon announces new CEO, Richard Jones

Retrieved on: 
Monday, February 14, 2022
University, Health, GlaxoSmithKline, CEO, Science, Cheminformatics, Leadership, Bristol Myers Squibb, Technology, The Ancestral Trail, Culture, Bayer, Research, Management, Csizmadia, ChemAxon

BUDAPEST, Hungary, Feb. 14, 2022 /PRNewswire/ -- Chemaxon, a leader in cheminformatics software development for life science research, announced the appointment of Richard Jones as Chief Executive Officer (CEO).

Key Points: 
  • BUDAPEST, Hungary, Feb. 14, 2022 /PRNewswire/ -- Chemaxon, a leader in cheminformatics software development for life science research, announced the appointment of Richard Jones as Chief Executive Officer (CEO).
  • We have great plans for the coming years, and we will be reaching out to our customers shortly to share them," comments Richard Jones, new CEO of Chemaxon.
  • "We have worked closely with Richard to align strategy and culture, in order to ensure Chemaxon's continued success.
  • The appointment coincides with Chemaxon Budapest offices moving to Vci Greens, a newly built eco-conscious office park on the eastern side of the Danube.

New year, New Beginning: Chemaxon announces new CEO, Richard Jones

Retrieved on: 
Monday, February 14, 2022
University, Health, GlaxoSmithKline, CEO, Science, Cheminformatics, Leadership, Bristol Myers Squibb, Technology, The Ancestral Trail, Culture, Bayer, Research, Management, Csizmadia, ChemAxon

BUDAPEST, Hungary, Feb. 14, 2022 /PRNewswire/ -- Chemaxon, a leader in cheminformatics software development for life science research, announced the appointment of Richard Jones as Chief Executive Officer (CEO).

Key Points: 
  • BUDAPEST, Hungary, Feb. 14, 2022 /PRNewswire/ -- Chemaxon, a leader in cheminformatics software development for life science research, announced the appointment of Richard Jones as Chief Executive Officer (CEO).
  • We have great plans for the coming years, and we will be reaching out to our customers shortly to share them," comments Richard Jones, new CEO of Chemaxon.
  • "We have worked closely with Richard to align strategy and culture, in order to ensure Chemaxon's continued success.
  • The appointment coincides with Chemaxon Budapest offices moving to Vci Greens, a newly built eco-conscious office park on the eastern side of the Danube.

Discngine partners up with ChemAxon to enhance its 3decision® platform for innovative structure-driven drug discovery

Retrieved on: 
Thursday, January 13, 2022
Research, Chemistry, Antibody, Cheminformatics, Partnership, Protein, ChemAxon, Bristol Myers Squibb, View, Data mining, Software as a service, Bayer, Multimedia, Peptide, Software, Decision-making, University, Knowledge management, GlaxoSmithKline, Fine chemical, Pharmaceutical industry

Discngine's 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base.

Key Points: 
  • Discngine's 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base.
  • The partnership with ChemAxon will bring the chemistry and biology capabilities of 3decision to a higher level.
  • Efi Hoffmann, ChemAxon co-CPO, adds:"It is crucial to keep innovating and grow with the market that we know so well.
  • In the coming weeks, Discngine and ChemAxon will host a joint event to elaborate on technical and scientific opportunities coming from the partnership.

Discngine partners up with ChemAxon to enhance its 3decision® platform for innovative structure-driven drug discovery

Retrieved on: 
Thursday, January 13, 2022
Research, Chemistry, Antibody, Cheminformatics, Partnership, Protein, ChemAxon, Bristol Myers Squibb, Data mining, Software as a service, Bayer, Peptide, Software, Decision-making, University, Knowledge management, GlaxoSmithKline, Fine chemical, Pharmaceutical industry

Discngine's 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base.

Key Points: 
  • Discngine's 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base.
  • The partnership with ChemAxon will bring the chemistry and biology capabilities of 3decision to a higher level.
  • Efi Hoffmann, ChemAxon co-CPO, adds:"It is crucial to keep innovating and grow with the market that we know so well.
  • In the coming weeks, Discngine and ChemAxon will host a joint event to elaborate on technical and scientific opportunities coming from the partnership.

Worldwide Chemoinformatics Industry to 2026 - Featuring Agilent Technologies, Bio-Rad Laboratories and ChemAxon Among Others

Retrieved on: 
Wednesday, December 1, 2021
Agilent Technologies, Information technology, Coronavirus, Industry, CAGR, Awareness, Therapy, COVID-19, Cheminformatics, ChemAxon, R, Research, Investment, Conditional sentence, Collection, Dassault Systèmes, Disease, Animal, Pharmaceutical industry

Chemoinformatics is a new field of information technology (IT) that focuses on the collection, storage, analysis, and manipulation of chemical data.

Key Points: 
  • Chemoinformatics is a new field of information technology (IT) that focuses on the collection, storage, analysis, and manipulation of chemical data.
  • Chemoinformatics helps define archival data protocols and represent three-dimensional (3D) molecular structures, which further enables searching and comparing of compounds with specific features.
  • As a result, it is widely used in the pharmaceutical industry to discover and develop novel biotechnological processes and products.
  • What is the structure of the global chemoinformatics market and who are the key players?

ChemAxon's Marvin JS Used for Creating Chemical Structure Files by NITE

Retrieved on: 
Tuesday, November 27, 2018
Bioinformatics, ChemAxon, Cheminformatics, Drug discovery, National Institute of Technology and Evaluation, Id, Nature, Computational science

The National Institute of Technology and Evaluation (NITE) rolled out their MOL file creation system on 14th of September, 2018.

Key Points: 
  • The National Institute of Technology and Evaluation (NITE) rolled out their MOL file creation system on 14th of September, 2018.
  • This system is used with ChemAxon's online chemical editor, Marvin JS implemented.
  • "We have decided to go with Marvin JS out of a single reason: it is really simple to integrate into any web environment and companies can generate MOL files easily,"NITE representative says.
  • NITE's platform allows us to stabilize our presence further by introducing our market leading online chemical editor, the Marvin JS to a wide audience.

SciBite and ChemAxon to Deliver an Integrated Solution for Biology and Chemistry Research

Retrieved on: 
Tuesday, May 8, 2018
ChemAxon

This partnership will bring deeper chemistry awareness to the SciBite platform.

Key Points: 
  • This partnership will bring deeper chemistry awareness to the SciBite platform.
  • ChemAxon will also integrate SciBite's unique semantic technology to deliver biology intelligence within its suite of applications, including ChemLocator.
  • "Our partnership with ChemAxon will bridge the gap between chemistry and biology and deliver unparalleled insights.
  • ChemAxon and SciBite share a similar philosophy, providing customers with interoperable, best of breed solutions to further power their next generation analytics," said Rob Greenwood, CEO of SciBite.